Cancer, Laparoscopic Abdominal Surgery, Right Colon Tumors, Robotic Surgical Procedures
Conditions
Keywords
right colon cancer, robotic surgery
Brief summary
This is a retrospective, multicenter cohort study to compare short- and long-term outcomes between robotic and laparoscopic hemicolectomy of right colon cancer.
Interventions
None listed
Sponsors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fudan University
The Second Affiliated Hospital of Harbin Medical University
Three Gorges Hospital of Chongqing University
The Affiliated Hospital of Qingdao University
The First Affiliated Hospital of Zhengzhou University
Tianjin Third Central Hospital
Shandong University Second Hospital
Nanfang Hospital, Southern Medical University
Huadong Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Xiangya Hospital of Central South University
Jiangxi Provincial People's Hopital
Pingxiang People 's Hospital
Ganzhou City People's Hospital
The First Affiliated Hospital of Nanchang University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* 1.Underwent radical right hemicolectomy by Da Vinci robotic or laparoscopic surgery 2.Postoperative pathology confirmed right colon adenocarcinoma (pT2-T4aNxM0; including cecal adenocarcinoma, ascending colon adenocarcinoma, hepatic flexure colon adenocarcinoma, and proximal transverse colon adenocarcinoma) 3.Complete clinical data and pathological results available
Exclusion criteria
* 1.Received neoadjuvant therapy prior to surgery 2.History of other malignancies in the past 5 years (except cured cervical carcinoma in situ, basal cell carcinoma, or squamous cell carcinoma of the skin) 3.Distant metastases (e.g., liver, lung) or extensive abdominal/pelvic metastases confirmed by contrast-enhanced CT, PET-CT, or intraoperative exploration 4.Comorbid neurological/psychiatric disorders impairing ability to express informed consent 5.Poor systemic condition with contraindications to general anesthesia 6.Severe obesity (BMI \>35 kg/m²) 7.Severe widespread abdominal adhesions precluding safe pneumoperitoneum establishment 8.Emergency surgery due to tumor perforation or obstruction 9.Refusal to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year overall survival (OS) rate and 3-year disease-free survival (DFS) rate | （OS）From post-operation until death or the 3-year study endpoint （DFS）From post-operation to tumor recurrence or the 3-year study endpoint |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intraoperative blood loss | Periprocedural | — |
| Time to first flatus/bowel movement | Periprocedural | — |
| Time to liquid diet initiation | Periprocedural | — |
| Time to ambulation | Periprocedural | — |
| Operative time | Periprocedural | — |
| Postoperative complications | From end of surgery to 30 days postoperatively | Surgery-related adverse events within 30 days, graded via the Clavien-Dindo classification system |
| Postoperative white blood cell (WBC) count | On postoperative days 1, 3, and 5 | Measured on postoperative days 1, 3, and 5 |
| Postoperative C-reactive protein (CRP) level | On postoperative days 1, 3, and 5 | Measured on postoperative days 1, 3, and 5 |
| Pain score | On postoperative days 1, 3, and 5 | Assessed using the Visual Analog Scale (VAS) on postoperative days 1, 3, and 5 |
| Postoperative hospital stay duration | Up to 30 days | — |
Outcome results
None listed